White matter changes in children treated for acute lymphoblastic leukemia

Area of Science:

• Pediatric Oncology
• Neuroimaging
• Leukemia Research

Background:

• Acute lymphoblastic leukemia (ALL) treatment often involves central nervous system (CNS) therapies.
• Long-term effects of CNS treatment on brain structure require careful monitoring.
• Understanding treatment-related neurotoxicity is crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate white matter changes in children with ALL after CNS treatment using magnetic resonance (MR) imaging.
• To compare the incidence of white matter changes between different CNS treatment modalities.
• To assess the sensitivity of MR imaging in detecting therapy-induced neurological changes.

Main Methods:

• Twenty-seven children with ALL underwent MR imaging post-CNS treatment.
• Patients received either methotrexate (intravenous/intrathecal) or cranial radiation therapy plus chemotherapy.
• Follow-up included clinical evaluations and computed tomographic (CT) brain scans.

Main Results:

• Fifteen percent (4/27) of children exhibited white matter changes on MR scans.
• White matter changes were observed in 19% of the radiation therapy group and 9% of the chemotherapy-only group.
• CT scans showed hypodensity in only one case, highlighting MR's sensitivity.

Conclusions:

• Both radiation therapy and chemotherapy, alone or combined, may cause white matter changes in children treated for ALL.
• MR imaging is a sensitive tool for detecting these therapy-related white matter changes.
• Longitudinal studies are necessary to determine the clinical significance and long-term impact of these MR findings.